Get Ocrevus at BioHealth Infusion Center
Ocrevus (ocrelizumab) is used to treat relapsing or primary progressive forms of multiple sclerosis (MS).
Ocrevus is a monoclonal antibody that targets CD20 positive B lymphocytes (a type of white blood cell), which contribute to nerve damage in MS. This may help to protect healthy cells from damage.
Getting Your Ocrevus Infusion
Ocrevus is usually administered by intravenous infusion every six months, after a starter dose that is split into two separate infusions, two weeks apart. Each infusion takes from 2-1/2 to 4 hours.
Patients are routinely given other medications at the same time to help prevent certain side effects of the drug.
Get Ocrevus at BioHealth Infusion Center and enjoy:
Perfect Medical Services
Schedule an Appointment
Our goal is to provide patients with courteous, prompt, and experienced infusion care. With just one phone call to the infusion center, the authorization process can begin immediately. All reimbursement and financial assistance options are explored in order to provide the patient’s infusion therapy at the lowest out-of-pocket costs to them.